GURUFOCUS.COM » STOCK LIST » Industrials » Business Services » Proto Script Pharmaceutical Corp (OTCPK:PSCR) » Definitions » Equity-to-Asset

Proto Script Pharmaceutical (Proto Script Pharmaceutical) Equity-to-Asset : -6.14 (As of Sep. 2017)


View and export this data going back to 2011. Start your Free Trial

What is Proto Script Pharmaceutical Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Proto Script Pharmaceutical's Total Stockholders Equity for the quarter that ended in Sep. 2017 was $-1.44 Mil. Proto Script Pharmaceutical's Total Assets for the quarter that ended in Sep. 2017 was $0.24 Mil. Therefore, Proto Script Pharmaceutical's Equity to Asset Ratio for the quarter that ended in Sep. 2017 was -6.14.

The historical rank and industry rank for Proto Script Pharmaceutical's Equity-to-Asset or its related term are showing as below:

PSCR's Equity-to-Asset is not ranked *
in the Business Services industry.
Industry Median: 0.5
* Ranked among companies with meaningful Equity-to-Asset only.

Proto Script Pharmaceutical Equity-to-Asset Historical Data

The historical data trend for Proto Script Pharmaceutical's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Proto Script Pharmaceutical Equity-to-Asset Chart

Proto Script Pharmaceutical Annual Data
Trend May12 May13 May14 May15 May16
Equity-to-Asset
-1.50 0.85 0.07 -44.00 -6.42

Proto Script Pharmaceutical Quarterly Data
Nov12 Feb13 May13 Aug13 Nov13 Feb14 May14 Aug14 Nov14 Feb15 May15 Aug15 Nov15 Feb16 May16 Sep16 Dec16 Mar17 Jun17 Sep17
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.08 -1.88 -3.61 -6.98 -6.14

Competitive Comparison of Proto Script Pharmaceutical's Equity-to-Asset

For the Specialty Business Services subindustry, Proto Script Pharmaceutical's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Proto Script Pharmaceutical's Equity-to-Asset Distribution in the Business Services Industry

For the Business Services industry and Industrials sector, Proto Script Pharmaceutical's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Proto Script Pharmaceutical's Equity-to-Asset falls into.



Proto Script Pharmaceutical Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Proto Script Pharmaceutical's Equity to Asset Ratio for the fiscal year that ended in May. 2016 is calculated as

Equity to Asset (A: May. 2016 )=Total Stockholders Equity/Total Assets
=-0.077/0.012
=

Proto Script Pharmaceutical's Equity to Asset Ratio for the quarter that ended in Sep. 2017 is calculated as

Equity to Asset (Q: Sep. 2017 )=Total Stockholders Equity/Total Assets
=-1.442/0.235
=-6.14

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Proto Script Pharmaceutical  (OTCPK:PSCR) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Proto Script Pharmaceutical Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Proto Script Pharmaceutical's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Proto Script Pharmaceutical (Proto Script Pharmaceutical) Business Description

Traded in Other Exchanges
N/A
Address
9830 6th Street, Suite 103, Rancho Cucamonga, CA, USA, 91730
Proto Script Pharmaceutical Corp is primarily in the business of repair power wheelchairs and scooters, which are classified as durable medical equipment (DME) products and reimbursable by healthcare insurance providers. It has various contracts with state and governmental insurance providers, among others. These contracts provide the company with the right to sell and repair DME and its health care insurance contracts allow it the ability to service patients nationally. The group currently has its presence of repair facilities in Las Vegas, Nevada, Rancho-Cucamonga, and Anaheim, California.

Proto Script Pharmaceutical (Proto Script Pharmaceutical) Headlines

No Headlines